Matinas BioPharma Holdings (MTNB) FCF Margin (QoQ) (2015 - 2023)
Matinas BioPharma Holdings (MTNB) FCF Margin (QoQ) (2015 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.22 Mn | 406,176.27 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 78,571.00 |
| Mar 31, 2023 | -68,149.00 |
| Dec 31, 2022 | 8,269.00 |
| Sep 30, 2022 | -320.00 |
| Mar 31, 2021 | -2.08 Mn |
| Dec 31, 2020 | 1.23 Mn |
| Jun 30, 2018 | 702,115.00 |
| Mar 31, 2018 | -518,373.00 |
| Dec 31, 2017 | 174,862.00 |
| Sep 30, 2017 | 202,368.00 |
| Jun 30, 2017 | 1.20 Mn |
| Sep 30, 2015 | -70,733.00 |
| Jun 30, 2015 | 111,590.00 |